Ranbaxy Laboratories Articles
Ranbaxy denies it forged drug data
21 July 2008
Pfizer may counter Daiichi Sankyo bid for Ranbaxy
23 June 2008
Daiichi Sankyo in deal to control Ranbaxy
16 June 2008
Foreign generics firms on offensive in Japan
2 June 2008
Ranbaxy moves into Yemen
26 May 2008
India's Orchid sets up subsidiary in Japan
21 April 2008
India to give neglected disease grants to drug firms
17 March 2008
53 firms seeking major stake in Antibiotice
11 February 2008
Generic settlements over Exelon and Imitrex
28 January 2008
Ranbaxy's FY 2007 profit up 68% $191M
28 January 2008
Dr Reddy's plans Japan generics JV
3 December 2007
Ranbaxy issues first Indian drug recall in USA
26 November 2007
Astellas/Boeh Ing settle with Ranbaxy over Flomax
12 November 2007
Ranbaxy's valsartan gets tentative FDA OK
5 November 2007
Pfizer to appeal Geman Lipitor patent decision
5 November 2007
Ranbaxy's 3rd-qtr net profit soars 48%
5 November 2007
Ranbaxy raises stake in Zenotech to 45%
15 October 2007
Tentative US appro for Ranbaxy's generic galantamine
10 September 2007
Ranbaxy and GSK settle over Valtrex
6 August 2007
Ranbaxy's 2nd-qtr profits soar 118%
30 July 2007
Pfizer wins Ireland Lipitor patent case
16 July 2007
Ranbaxy buys 13 B-MS dermatology drugs
4 June 2007
Ranbaxy gets US approval for generic loratadine
16 April 2007
Ranbaxy withdraws bid for Merck KGaA's generics arm
26 March 2007
Ranbaxy bids for Merck KGaA's generics arm
19 March 2007
PPD licenses Ranbaxy's novel statin
5 March 2007
Expert group warns India's govt on patents
19 February 2007
Ranbaxy and GSK expand strategic alliance
12 February 2007
Ranbaxy gains final approval for generic valacyclovir
12 February 2007
Ranbaxy's 2006 net profit soars 97%
29 January 2007
Ranbaxy shows interest in Merck KGaA's generic business
15 January 2007
Atenolol gets US regulatory go-ahead
8 January 2007
Final US OK for Ranbaxy's cefprozil
22 December 2006
Favorable US court ruling for Ranbaxy over simvastatin
20 November 2006
Ranbaxy's profits for 2nd-qtr hit 1.4B rupees
6 November 2006
Indian drug prices to fall, says Minister
2 October 2006
Gilead signs eight generic Viread licenses
2 October 2006
Ranbaxy's generic furosemide cleared in USA
25 September 2006
Torrent opens Australian unit with six new NDAs
18 September 2006
Ranbaxy Labs granted two atorvastatin patents in Norway
4 September 2006
UK Appeals Court affirms earlier ruling
10 July 2006
FDA approves Ranbaxy's generic simvastatin 80mg
3 July 2006
Ranbaxy signs deals with Zenotech and Terapia
19 June 2006
UK fraud investigation over drugs price-fixing
10 April 2006
Another buy for Ranbaxy: Ethimed
3 April 2006
India's Ranbaxy on European buying spree
3 April 2006
Ranbaxy accord with Zenotech
20 March 2006
India's "big pharma" is now the target
27 February 2006
Pfizer wins Ranbaxy Lipitor injunction
27 February 2006
Indian firms set to step up Tamiflu production
19 December 2005
Ranbaxy India launches high compliance ARVs
12 December 2005
Ranbaxy sets up Italian subsidiary
19 September 2005
Ranbaxy Laboratories opens drug discovery center in India
5 September 2005
Ranbaxy Pharma gets tentative FDA nod for sumatriptan
8 August 2005
Better 2nd-qtrs for most Indian drugmakers
8 August 2005
Zimbabwe's Datlabs allies with Ranbaxy
1 August 2005
Tentative FDA appro for Ranbaxy and Aurobindo
4 July 2005
Ranbaxy Labs lamivudine gets US FDA approval
13 June 2005
Ranbaxy post worst qtr, with net -63%
9 May 2005
Ranbaxy files further ARVs with WHO
4 April 2005
Ranbaxy files further ARVs with WHO
4 April 2005
Tentative FDA appro for Ranbaxy's donepezil
7 March 2005
Ranbaxy profit down despite sales hike
31 January 2005
Ranbaxy gives HIV update
17 January 2005
FDA OKs Ranbaxy's generic fosinopril
10 January 2005
FDA OKs Ranbaxy's generic Prozac
20 December 2004
Ranbaxy withdraws generic antiretrovirals on quality concerns
15 November 2004
Ranbaxy's 3rd-qtr 2004 sales jump 19%
1 November 2004
Ranbaxy aims for $2B generics sales by 2007
27 September 2004
Ranbaxy to expand to Canada and Portugal
6 September 2004
Asian companies are now targeting Japanese pharma market
16 August 2004
Ranbaxy UK in generic drugs price row
5 July 2004
Ranbaxy debuts chewable cephalosporin tab
28 June 2004
Ranbaxy reports cefuroxime case win
19 April 2004
Ranbaxy launches Riomet, the first liquid metformin
1 March 2004
Ranbaxy reports 2003 global sales up 22%
9 February 2004
Ranbaxy 5th largest generics firm in France
5 January 2004
Ranbaxy strikes deal for Aventis' RPG
22 December 2003
Indian pharma firms' quarterly profits/sales sharply higher
10 November 2003
Tokyo pharma stocks - week to Sept 29
3 November 2003
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
